Cutaneous leishmaniasis treated with azithromycin in a child

Area of Science:

• Dermatology
• Infectious Diseases
• Parasitology

Background:

• Cutaneous leishmaniasis is a parasitic skin disease caused by Leishmania parasites.
• Leishmania major is a common species responsible for zoonotic cutaneous leishmaniasis.
• Effective and accessible treatments for cutaneous leishmaniasis are crucial.

Observation:

• A 10-year-old boy presented with cutaneous leishmaniasis.
• The infection was presumed to be caused by Leishmania major.
• The patient received oral azithromycin for treatment.

Findings:

• The oral azithromycin treatment was successful in resolving the cutaneous leishmaniasis.
• This case suggests azithromycin is a viable therapeutic option for Leishmania major infections.
• Review of clinical studies supports azithromycin's efficacy in cutaneous leishmaniasis.

Implications:

• Oral azithromycin offers a promising treatment strategy for cutaneous leishmaniasis.
• This finding could lead to wider use of azithromycin in managing this neglected tropical disease.
• Further clinical research is warranted to establish optimal azithromycin dosing and long-term outcomes.